Zhao Xudong, Zhou Sixin, Liu Na, Li Peiyu, Chen Lin
Senior Department of General Surgery, the First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Front Oncol. 2022 May 26;12:892027. doi: 10.3389/fonc.2022.892027. eCollection 2022.
The aim of the present study was to explore the feasibility and safety of the surgical resection of presacral tumors a transsacrococcygeal transverse incision.
The clinical data and prognoses of patients with presacral tumors who underwent surgery at the Chinese People's Liberation Army (PLA) General Hospital between January 2009 and December 2018 were retrospectively reviewed and analyzed.
A total of 110 patients with presacral tumors were included in this study, including 82 female patients and 28 male patients, with a female-to-male ratio of 2.9:1. A posterior approach (transsacrococcygeal transverse incision) was utilized in 105 patients, an anterior approach (transabdominal excision) was utilized in 1 patient, and a combined (posterior plus anterior) approach was utilized in 4 patients. The mean tumor size was 8.72 ± 4.28 cm. More than half of the patients (n=59/110) with presacral tumors were asymptomatic. Twenty-six pathological types were observed in our study, including 97 benign lesions and 13 malignant lesions. The intraoperative complication rate was 42.7% (n=47/110), whereas the postoperative morbidity rate was 3.6% (n=4/110). The length of hospital stay for patients treated with the posterior approach was shorter than that of patients treated with the anterior and combined approaches. After a mean follow-up of 90.13 ± 31.22 months, 11 patients had local presacral tumor recurrence, and 1 patient had distant metastasis, with a combined recurrence rate of 10.9% (n=12/110).
The surgical resection of primary presacral tumors a transsacrococcygeal transverse incision is feasible and safe, with acceptable oncological therapeutic outcomes and a low postoperative morbidity rate, making it worth popularizing in clinical practice.
本研究旨在探讨经骶尾横切口手术切除骶前肿瘤的可行性和安全性。
回顾性分析2009年1月至2018年12月在中国人民解放军总医院接受手术治疗的骶前肿瘤患者的临床资料和预后情况。
本研究共纳入110例骶前肿瘤患者,其中女性82例,男性28例,男女比例为2.9:1。105例患者采用后路手术(经骶尾横切口),1例患者采用前路手术(经腹切除术),4例患者采用联合手术(后路加前路)。肿瘤平均大小为8.72±4.28cm。超过半数(n=59/110)的骶前肿瘤患者无症状。本研究观察到26种病理类型,包括97例良性病变和13例恶性病变。术中并发症发生率为42.7%(n=47/110),术后发病率为3.6%(n=4/110)。后路手术患者的住院时间短于前路和联合手术患者。平均随访90.13±31.22个月后,11例患者出现骶前肿瘤局部复发,1例患者出现远处转移,总复发率为10.9%(n=12/110)。
经骶尾横切口手术切除原发性骶前肿瘤是可行且安全的,肿瘤治疗效果可接受,术后发病率低,值得在临床实践中推广。